Intrinsiqs

Is Lexeo Therapeutics, Inc. Common Stock overvalued?

Lexeo Therapeutics, Inc. Common Stock (LXEO) — key valuation metrics and fundamentals.

No verdict
Price
$3.14
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$246.6M
Dividend yield
0.0%
Return on equity
-41.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares LXEO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.